MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Treatment"

  • 2023 International Congress

    Benefit of multiple incobotulinumtoxinA injections for pain reduction in adults with cervical dystonia: an analysis of pooled data

    A. Albanese, J. Wissel, W. Jost, A. Castagna, M. Althaus, G. Comes, A. Scheschonka, M. Vacchelli, H. Jinnah (Rozzano, Italy)

    Objective: To assess the long-term effects of repeated incobotulinumtoxinA (inco-A) injections on cervical dystonia (CD)-related pain in a pooled analysis of studies in adults with…
  • 2023 International Congress

    New DBS targets for dystonia in thalamus and brainstem

    T. Sanger, J. Maclean, J. Olaya, M. Liker (Orange, USA)

    Objective: Our objective is to describe experience with new targets for deep brain stimulation in children with genetic or acquired dystonias. Background: Although DBS has…
  • 2023 International Congress

    The efficacy of thalamic and pallidal deep brain stimulation rescue leads in dystonic tremor depends on the affected body region – a case series

    S. Paschen, J. Becktepe, M. Hobert, K. Zeuner, A. Helmers, D. Berg, G. Deuschl (Kiel, Germany)

    Objective: We aim to investigate whether the body region affected by dystonic tremor and dystonia is important for target selection. Background: For the treatment of…
  • 2023 International Congress

    Pain reduction in adults with cervical dystonia and moderate or severe baseline pain following repeated injections of incobotulinumtoxinA: an analysis of pooled data from phase 3 and 4 studies

    A. Albanese, J. Wissel, W. Jost, A. Castagna, M. Althaus, G. Comes, A. Scheschonka, M. Vacchelli, H. Jinnah (Rozzano, Italy)

    Objective: To assess pain reduction in incobotulinumtoxinA (incoA)-treated adults with cervical dystonia (CD)-related moderate or severe pain at baseline using pooled data from four phase…
  • 2023 International Congress

    Patient characteristics and real-world use of botulinum toxins for treatment of cervical dystonia and blepharospasm

    M. Hast, A. Kong, S. Desai, S. Syed, J. Holmes (Raleigh, USA)

    Objective: To describe the characteristics of patients with cervical dystonia (CD) or blepharospasm (BLEPH) treated with botulinum toxin (BoNT) in routine care using claims data…
  • 2023 International Congress

    The use of pallidal deep brain stimulation (GPi-DBS) to treat GNAO1 gene associated hyperkinetic syndromes

    A. Costa, D. Oliveira, M. Malaquias, L. Botelho, C. Silva, E. Cunha, V. Sá Pinto, N. Vila-Chã, I. Carrilho, M. Magalhães, A. Mendes (Porto, Portugal)

    Objective: To describe the clinical features and benefits of GPi-DBS approach in two patients with GNAO1 gene mutations to whom several episodes of choreo-dystonia exacerbations…
  • 2023 International Congress

    Updates on the Outcomes of Botulinum Toxin Injections in Patients with Lower Limb Dystonia

    M. Wajid, J. Yu, J. Frey, J. Lopes, A. Dave, L. Kugler, T. Stiep, J. Toledo, A. Ramirez-Zamora, A. Rawls, A. Wagle Shukla, I. Malaty (Gainesville, USA)

    Objective: To assess the therapeutic outcomes of botulinum toxin injections (BoNT) in patients with lower limb dystonia (LLD). Background: BoNT to the affected muscle groups…
  • 2023 International Congress

    A case of dystonia-predominant spinocerebellar ataxia type 3 treated with bilateral deep brain stimulation to the globus pallidus internal segment

    D. Rodriguez Gomez, B. Dalm, V. Khurana, C. Goas, Z. Jordan, B. Changizi (Boston, USA)

    Objective: To present a case of Spinocerebellar Ataxia type 3 (SCA3) with generalized dystonia as the predominant clinical phenotype treated with bilateral globus pallidus internus…
  • 2023 International Congress

    Role of bilateral pallidotomy in status dystonicus

    K. Garg, M. Singh, R. Rajan (New Delhi, India)

    Objective: The purpose of this study is to retrospectively review the results of bilateral pallidotomy in patients presenting with status dystonicus. Background: Dystonias, third commonest…
  • 2023 International Congress

    An uncommon task specific dystonia masquerading as Myasthenia Gravis

    R. Robinson, J. Mcconville, J. Craig, K. Doherty (Belfast, United Kingdom)

    Objective: We present a case of late onset task specific segmental (cervico-lingual) dystonia misdiagnosed as bulbar myasthenia gravis. Background: Muscle diseases have been previously reported to mimic…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 39
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #28970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley